Pro Medicus boosts share buy-back, directors increase holdings

Pro Medicus Limited (ASX:PME) announced an update to its on-market share buy-back program. The company bought back 3,200 ordinary fully paid shares on December 18, 2025, bringing the total number of shares bought back to 48,524. The total consideration paid for shares bought back before December 18 was AUD 10,951,818.28, with an additional AUD 687,080.64 for shares on December 18. The highest price paid on December 18 was AUD 216.66, and the lowest was AUD 211.01. The company intends to buy back a maximum of 10,447,056 securities through Goldman Sachs. The buy-back commenced on April 1, 2025, and is scheduled to conclude on March 31, 2026.

In related director interest notices, Sam Aaron Hupert acquired 2,250 ordinary shares in an on-market trade on December 22, 2025, at AUD 221.45 per share, increasing his total holdings to 24,189,910 ordinary shares. Similarly, Anthony Barry Hall also acquired 2,250 ordinary shares on December 22, 2025, through an on-market trade at AUD 221.90 per share, bringing his total holdings to 24,146,250 ordinary shares. These acquisitions were made outside of a closed period.